ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BGMD BG Medicine Inc (CE)

0.000001
0.00 (0.00%)
27 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
BG Medicine Inc (CE) USOTC:BGMD OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 00:00:00

BG Medicine Announces Q1 2015 Financial Results Release Date and Conference Call Information

07/05/2015 10:00pm

GlobeNewswire Inc.


BG Medicine (CE) (USOTC:BGMD)
Historical Stock Chart


From Jan 2020 to Jan 2025

Click Here for more BG Medicine (CE) Charts.

BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, May 14, 2015 at 8:30 a.m. Eastern Time to discuss its Q1 2015 financial results before the market opens.

Conference Call Details

The conference call may be accessed by dialing (877) 845-1016 from the U.S. and Canada, or (708) 290-1155 from international locations. The conference call will also be available via the Internet at  www.bg-medicine.com.

Listeners are encouraged to login at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software.

To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's website at  www.bg-medicine.com.  Please connect to the website at least 15 minutes prior to the call to download and install any necessary audio software.

About BG Medicine

BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit   www.BG-Medicine.com. The BG Medicine Inc. logo is available for download   here.

CONTACT: Stephen Hall
         EVP & Chief Financial Officer
         (781) 890-1199

1 Year BG Medicine (CE) Chart

1 Year BG Medicine (CE) Chart

1 Month BG Medicine (CE) Chart

1 Month BG Medicine (CE) Chart